Brief: Galera Announces FDA Orphan Drug Designation Granted To Rucosopasem For Pancreatic Cancer

Obsidian Therapeutics

18/05/2023 13:10

Galera Therapeutics Inc  GRTX.O :
    * GALERA ANNOUNCES FDA ORPHAN DRUG DESIGNATION GRANTED TO
RUCOSOPASEM FOR PANCREATIC CANCER
    * GALERA ANNOUNCES FDA ORPHAN DRUG DESIGNATION GRANTED TO
RUCOSOPASEM FOR PANCREATIC CANCER
    * GALERA THERAPEUTICS- BELIEVE RUCOSOPASEM HAS POTENTIAL TO
IMPROVE EFFICACY OF SBRT FOR PANCREATIC CANCER, SEES TOPLINE
DATA FROM GRECO-2 BY END OF NEXT YEAR

Source text for Eikon:  ID:nGNXDwt9x 
Further company coverage:  GRTX.O